Printer Friendly

Accuray announces receipt of FDA 510(k) Clearance for new CyberKnife M6 Series with heightened efficiency.

M2 EQUITYBITES-November 2, 2012-Accuray announces receipt of FDA 510(k) Clearance for new CyberKnife M6 Series with heightened efficiency(C)2012 M2 COMMUNICATIONS http://www.m2.com

Radiation oncology company Accuray Incorporated (Nasdaq:ARAY) said on Thursday that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its new CyberKnife M6 Series with expanded clinical capabilities, reduced treatment times and an enhanced patient experience.

The company's new CyberKnife M6 FIM and FM Systems, which features the InCise Multileaf Collimator, combines the benefits of beam shaping with the flexibility of non-isocentric, non-coplanar delivery offering unmatched clinical capabilities and expanding the number of patients eligible for treatment.

This new approved InCise Multileaf Collimator was designed specifically for stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments, giving the system the capability to extend its radiosurgical accuracy into a broader field of applications, meeting radiosurgery and radiotherapy needs.

With the addition of the InCise Multileaf Collimator, the CyberKnife M6 Series can be used to treat large and irregular tumors more efficiently with excellent dose gradients, according to the company.

((Comments on this story may be sent to info@m2.com))

COPYRIGHT 2012 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Nov 2, 2012
Words:194
Previous Article:DLM gets takeover approaches for operating units.
Next Article:Corning Incorporated acquires BD Discovery Labware business, expanding llife sciences product portfolio & geographic reach.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters